Medical Innovation Exchange

Cassava claims win in open-label Alzheimer's study, but shares decline 15%

https://www.fiercebiotech.com/biotech/cassava-claims-win-open-label-alzheimers-study-shares-decline-15

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!